BioSpace News Archive

Zogenix today announced that it will host a key opinion leader (KOL) webinar on thymidine kinase 2 deficiency (TK2d) and MT-1621 on Monday, November 8, 2021, at 12:00 PM Eastern Time.

Avadel Pharmaceuticals plc announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, November 8, 2021, to provide a corporate update and discuss the Company’s financial results for the third quarter ended September 30, 2021.

Checkmate Pharmaceuticals, Inc. today announced that final clinical data from the Phase 1b study, CMP-001-001, of vidutolimod, an advanced generation Toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab or as a monotherapy will be presented at The Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting to be held in person and virtually November 10-14, 2021.

NextCure, Inc. today announced that the company will host a Virtual Oncology Pipeline Update Event at 4:30 p.m. ET on Monday, November 15, 2021.

Science 37 Holdings, Inc. today announced it will report third quarter 2021 financial results before the market opens on Monday, November 15, 2021.

F-star Therapeutics, Inc. announced today that the Company will hold a conference call and webcast on November 10, 2021, at 9:00 a.m. EST to review third quarter 2021 financial results and provide a corporate update.

Candel Therapeutics, Inc. today announced its participation in upcoming medical and scientific conferences.

Kiniksa Pharmaceuticals, Ltd. today reported third quarter 2021 financial results and recent portfolio execution.

Kinnate Biopharma Inc. today announced a collaboration with Guardant Health, a leading precision oncology company, focused on characterizing the prevalence of patients with advanced solid tumors bearing BRAF Class I, II and III alterations.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it presented new data from its movement disorder program for tardive dyskinesia (TD) at the 2021 Psych Congress scientific meeting being held October 29–November 1, 2021.